Health care stocks leaned lower premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was down 0.5% and the iShares Biotechnology ETF (IBB) declined by 1.6% recently.
Owens & Minor (OMI) shares fell past 1% after the company said it expects to record a Q4 non-cash goodwill impairment charge in its Apria division of about $310 million, or around a $4 net loss per share. The company also reported preliminary Q4 revenue that missed market expectations.
Becton Dickinson (BDX) is considering a potential separation of its life sciences division, according to media reports. Becton Dickinson shares were up over 0.5% pre-bell.
GH Research (GHRS) shares rose past 89% after the company said a phase 2b clinical trial of GH001 for patients with treatment-resistant depression met its primary endpoint.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.